Состояние репродуктивной функции и критерии компенсации заболевания у взрослых пациентов с классическими формами врожденной дисфункции коры надпочечников

1. Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet 2005; 365: 2125–36.
2. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000; 21: 245–91.
3. Arlt W, Willis DS, Wild SH et al. Health Status of Adults with Congenital Adrenal Hyperplasia: A Cohort Study of 203 Patients. J Clin Endocrinol Metab 2010; 95 (11): 5110–21.
4. Reisch N, Krone N, Hughes BA et al. The role of serum and urinary steroids in the monitoring of adults with congenital adrenal hyperplasia. Endocrine Abstracts 2009; 19; P337.
5. Padidela R, Hindmarsh PC. Mineralocorticoid Deficiency and Treatment in Congenital Adrenal Hyperplasia. Int J Pediatr Endocrinology 2010: 1–4.
6. Meyer-Bahlburg HFL. What causes low rates of child-bearing in congenital adrenal hyperplasia? J Clin Endocrinol Metab 1999; 84: 1844–7.
7. Krone N, Wachter I, Stefanidou M et al. Mothers with congenital adrenal hyperplasia and their children: outcome of pregnancy, birth and childhood. Clin Endocrinol (Oxf) 2001; 55: 523–9.
8. Lo JC, Grumbach MM. Pregnancy outcomes in women with congenital virilizing adrenal hyperplasia. Endocrinol Metab Clin North Am 2001; 30: 207–29.
9. Premawardhana LD, Hughes IA, Read GF, Scanlon MF. Longer tem outcome in females with congenital adrenal hyperplasia (CAH): the Cardiff experience. Clin Endocrinol (Oxf) 1997; 46: 327–32.
10. Holmes-Walker DJ, Conway GS et al. Menstrual disturbance and hypersecretion of progesterone in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol (Oxf) 1995; 43: 291–6.
11. Hagenfeldt PO, Janson G, Holmdahl H et al. Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod 2008; 23 (7): 1607–13.
12. Mulaikai RM, Migeon CJ, Rock JA. Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 1987; 316: 178–82.
13. Alizai NK, Thomas DFM, Lilford TRJ et al. Feminizing genitoplasty for congenital adrenal hyperplasia: What happens at puberty? J Urol 1999; 161: 1588–91.
14. Krege S, Walz KH, Hauffa BP et al. Long-term follow-up of female patients with congenital adrenal hyperplasia from 21-hydroxylase deficiency, with special emphasis on the results of vaginoplasty. BJU Int 2000; 86: 253–9.
15. Schober JM. Feminizing genitoplasty for intersex. In: Stringer MD, Oldham KT, and Moriquand PDE, and Howard BR eds. Pediatric surgery and urology: Long term outcomes. Saunders, Philadelphia, 1998; p. 549–58.
16. British Association of Paediatric Surgeons (2001) Statement of the British Paediatric Surgeons Working Party on the management of children born with ambiguous genitalia.
17. Файзулин А.К., Батыгин М.П., Глыбина Т.М., Шкитырь З.В. Современные методы хирургической коррекции пороков наружных гениталий у девочек с врожденной дисфункцией коры надпочечников. Андрология и генитальная хирургия. 2011; 3: 69–73.
18. Зубкова Н.А., Дворянчиков Н.В., Окулов А.Б., Касаткина Э.П. Психосексуальный статус больных с врожденной дисфункцией коры надпочечников. Успехи теоретической и клинической медицины: материалы научных исследований РМАПО. М., 2003; с. 228–9.
19. Money J, Schwartz M, Lewis VG. Adult erotosexual status and fetal hormonal masculinization and demasculinization: 46, XX congenital virilizing adrenal hyperplasia and 46,XY androgen-insensitivity syndrome compared. Psychoneuroendocrinology 1984; 9: 405–14.
20. Ogilvie CM, Crouch NS, Rumsby G et al. Congenital adrenal hyperplasia in adults: a review of medical, surgical and psychological issues. Clin Endocrinol (Oxf) 2006; 64: 2–11.
21. Urban MD, Lee PA, Migeon CJ. Adult height and fertility in men with congenital virilizing adrenal hyperplasia. N Engl J Med 1978; 299: 1392–6.
22. Hayes FJ, Decruz S, Seminara SB et al. Differential regulation of gonadotropin secretion by testosterone in the human male: absence of a negative feedback effect of testosterone on follicle-stimulating hormone secretion. J Clin Endocrinol Metab 2001; 86: 53–8.
23. Cabrera MS, Vogiatzi MG, New MI. Long term outcome in adult males with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001; 86: 3070–8.
24. Avila NA, Shawker TS, Jones JV et al. Testicular adrenal rest tissue in congenital adrenal hyperplasia: serial sonographic and clinical findings. AJR Am J Roentgenol 1999; 172: 1235–8.
25. Bonaccorsi AC, Adler I, Figueiredo JG. Male infertility due to congenital adrenal hyperplasia: testicular biopsy findings, hormonal evaluation, and therapeutic results in three patients. Fertil Steril 1987; 47: 664–70.
26. Walker BR, Skoog SJ, Winslow BH et al. Testis sparing surgery for steroid unresponsive testicular tumors of the adrenogenital syndrome. J Urol 1997; 157: 1460–3.
27. Davis JM, Woodroof J, Sadasivan R. Case report: congenital adrenal hyperplasia and malignant Leydig cell tumour. Am J of the Med Sci 1995; 309: 63–5.
28. Claahsen-van der Grinten HL, Otten BJ et al. Testicular adrenal rest tumours in adult males with congenital adrenal hyperplasia: evaluation of pituitary-gonadal function before and after successful testis-sparing surgery in 8 patients. J Clin Endocrinol Metab 2007; 92: 612.
29. Speiser PW, Azziz R, Baskin LS et al. A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency. Int J Pediatr Endocrinol 2010; 95: 4133–60.
30. Helleday J, Siwers B, Ritzen EM, Carlstrom K. Subnormal androgen and elevated progesterone levels in women treated for congenital virilizing 21-hydroxylase deficiency. J Clin Endocrinol Metab 1993; 76: 933–6.
31. Hague WM, Adams J, Rodda C et al. The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives. Clin Endocrinol (Oxf) 1990; 33: 501–10.

А.И.Сазонова1, Н.В.Молашенко2, Е.А.Трошина2

1. Терапевтическое отделение ФГБУ Научный центр акушерства, гинекологии и перинатологии им. акад. В.И.Кулакова 
Минздрава России, Москва;
2. Отделение терапии с группой ожирения ФГБУ Эндокринологический научный центр Минздрава России, Москва